Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 04, 2022

SELL
$48.09 - $57.79 $1.15 Million - $1.38 Million
-23,898 Closed
0 $0
Q4 2021

Jan 27, 2022

SELL
$47.19 - $62.68 $811,762 - $1.08 Million
-17,202 Reduced 41.85%
23,898 $1.25 Million
Q3 2021

Oct 29, 2021

SELL
$56.91 - $67.81 $117,291 - $139,756
-2,061 Reduced 4.78%
41,100 $2.46 Million
Q2 2021

Jul 26, 2021

SELL
$64.02 - $71.72 $32,650 - $36,577
-510 Reduced 1.17%
43,161 $2.93 Million
Q1 2021

Apr 27, 2021

BUY
$53.26 - $68.08 $37,708 - $48,200
708 Added 1.65%
43,671 $2.86 Million
Q4 2020

Jan 25, 2021

SELL
$43.41 - $56.51 $101,232 - $131,781
-2,332 Reduced 5.15%
42,963 $2.42 Million
Q3 2020

Nov 06, 2020

SELL
$47.43 - $60.75 $62,844 - $80,493
-1,325 Reduced 2.84%
45,295 $2.2 Million
Q2 2020

Jul 23, 2020

SELL
$43.51 - $66.59 $107,208 - $164,077
-2,464 Reduced 5.02%
46,620 $2.6 Million
Q1 2020

Apr 30, 2020

SELL
$32.82 - $81.13 $29,636 - $73,260
-903 Reduced 1.81%
49,084 $2.49 Million
Q4 2019

Jan 21, 2020

SELL
$60.96 - $77.7 $107,716 - $137,295
-1,767 Reduced 3.41%
49,987 $3.87 Million
Q3 2019

Oct 29, 2019

SELL
$55.78 - $68.08 $37,651 - $45,954
-675 Reduced 1.29%
51,754 $3.28 Million
Q2 2019

Jul 29, 2019

SELL
$53.69 - $65.47 $40,643 - $49,560
-757 Reduced 1.42%
52,429 $3.07 Million
Q1 2019

Apr 30, 2019

SELL
$44.53 - $58.9 $611,842 - $809,286
-13,740 Reduced 20.53%
53,186 $3.02 Million
Q4 2018

Feb 01, 2019

SELL
$47.64 - $71.26 $97,137 - $145,299
-2,039 Reduced 2.96%
66,926 $3.32 Million
Q3 2018

Nov 05, 2018

BUY
$52.03 - $71.41 $601,883 - $826,070
11,568 Added 20.15%
68,965 $4.9 Million
Q2 2018

Jul 24, 2018

BUY
$48.15 - $56.68 $2.76 Million - $3.25 Million
57,397 New
57,397 $2.99 Million

Others Institutions Holding NUVA

About NUVASIVE INC


  • Ticker NUVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 52,061,000
  • Description
  • NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...
More about NUVA
Track This Portfolio

Track Janney Montgomery Scott LLC Portfolio

Follow Janney Montgomery Scott LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janney Montgomery Scott LLC with notifications on news.